相关实验视频
Updated: May 6, 2026
13:33
Infinium Assay for Large-scale SNP Genotyping Applications
Published on: November 19, 2013
41.3K
探索药物遗传景观:通过罗马尼亚全国医疗测试实验室确定临床相关的基因型
Cristina Pop1, Antoanela Curici2,3, Oliviu Voștinaru1
1Pharmacology, Physiology and Pathophysiology, Department 2-Pharmacy, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania.
Pharmaceuticals (Basel, Switzerland)
|June 27, 2025
概括
药物遗传学测试揭示了影响药物反应的遗传倾向. 超过56%的受试者表现出CYP2D6,CYP2C9和CYP2C19的变异,强调了个性化药物治疗的必要性.
科学领域:
- 药物基因组学 药物基因组学
- 临床遗传学 临床遗传学
- 医学实验室科学 医学实验室科学
背景情况:
- 药物遗传学测试识别了影响药物的疗效和安全性的遗传因素.
- 赛内沃实验室从2017年到2023年进行了药物遗传测试的描述性分析.
- 这项研究侧重于关键基因 (CYP2D6,CYP2C9,CYP2C19) 和遗传变异 (TPMT,Factor V Leiden).
研究的目的:
- 分析2017年至2023年期间进行的药物遗传试验结果.
- 提供患者人口统计和基因型化结果的描述性概述.
- 评估在测试人群中影响药物治疗的遗传变异的流行程度.
主要方法:
- 评估了来自31,453个药物遗传试验的数据.
- 分析包括CYP2D6,CYP2C9,CYP2C19,TPMT和V因子莱登基因型.
- 人口统计数据和基因定型结果被收集并进行统计分析.
主要成果:
- 很大一部分患者表现出基因变异:56% (CYP2D6),41% (CYP2C9),52% (CYP2C19),12% (TPMT) 和16% (V因子莱登).
- 大多数接受测试的患者是女性 (80%),在31-40 (45%) 和19-30 (38%) 年龄组的患病率最高.
- 这些变异表明影响药物治疗疗效或安全的潜在风险.
结论:
- 药物遗传测试为个性化药物治疗提供了宝贵的见解.
- 医疗专业人员的兴趣有所增加,但临床实施面临挑战.
- 药物遗传学测试的常规整合需要解决当前的障碍.
相关概念视频
01:29Pharmacogenetics and Pharmacogenomics: Overview
264
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
264
01:27Principles of Pharmacogenetics: Types of Genetic Variants
143
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
143
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
160
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
160
01:27Pharmacogenetics of Drug Metabolism: Overview
196
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
196
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
84
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84
01:29Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129